StockNews.com initiated coverage on shares of Mannatech (NASDAQ:MTEX – Free Report) in a research note published on Saturday. The brokerage issued a buy rating on the stock.
Mannatech Price Performance
Mannatech stock opened at $9.40 on Friday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.74 and a current ratio of 1.25. The company has a market capitalization of $17.87 million, a price-to-earnings ratio of -11.60 and a beta of 0.98. Mannatech has a 1 year low of $6.75 and a 1 year high of $16.49. The company’s 50 day simple moving average is $10.12 and its 200-day simple moving average is $10.26.
Mannatech (NASDAQ:MTEX – Get Free Report) last issued its quarterly earnings results on Wednesday, March 26th. The company reported $1.20 earnings per share (EPS) for the quarter. The company had revenue of $29.01 million during the quarter. Mannatech had a negative net margin of 1.26% and a negative return on equity of 15.62%.
Mannatech Company Profile
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Featured Stories
- Five stocks we like better than Mannatech
- Best Aerospace Stocks Investing
- AST SpaceMobile: 5 Reasons to Buy This Tiny Trailblazer Stock
- 3 Dividend Kings To Consider
- Why Call Option Traders Are Targeting This Dividend ETF Now
- Golden Cross Stocks: Pattern, Examples and Charts
- Is Alphabet Misunderstood? Here’s Why the Bulls Are Buying
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
